Crinetics Pharmaceuticals, Inc.

Siren, L.L.C. CRNX
Report date
3/31/2026
Quarter
2026 Q1
Filed
5/14/2026
Shares
1,903,636
Value ($000)
69,140
Weight
1.9%
2024 Q3 - 2026 Q1 (7 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).